BlackRock Investment Management, LLC - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 51 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2015. The put-call ratio across all filers is 5.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q4 2016$99,000
-44.1%
50,3170.0%0.00%
Q3 2016$177,000
-1.7%
50,317
+0.0%
0.00%
Q2 2016$180,000
-11.8%
50,314
+19.1%
0.00%
Q1 2016$204,000
-16.4%
42,241
+2.1%
0.00%
Q4 2015$244,000
-0.4%
41,3760.0%0.00%
Q3 2015$245,000
-57.2%
41,376
-1.7%
0.00%
-100.0%
Q2 2015$573,000
+262.7%
42,082
+240.6%
0.00%
Q1 2015$158,000
+79.5%
12,357
+44.4%
0.00%
Q4 2014$88,0008,5550.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,492,975$3,597,974,0001.05%
&PARTNERS 51,961$42,0000.06%
Glassman Wealth Services 72,366$58,0000.02%
Sigma Planning Corp 385,737$309,0000.02%
HBK Sorce Advisory LLC 100,000$80,0000.01%
Fore Capital, LLC 56,300$45,0000.01%
WealthTrust Axiom LLC 17,320$13,0000.01%
B. Riley Wealth Management, Inc. 40,800$33,0000.01%
Semmax Financial Advisors Inc. 7,290$6,0000.00%
Ausdal Financial Partners, Inc. 10,025$9,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders